Current Venous Thromboembolism Management and Outcomes in Japan
Authors:
Open Access
- 1 January 2014
- journal article
- clinical trial
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 78 (3) , 708-717
Abstract
Background: Epidemiology and clinical management of acute venous thromboembolism (VTE) are not readily available in Japan. Methods and Results: The Japan VTE Treatment Registry (JAVA) is a multicenter cohort study of consecutive patients with an objectively confirmed, symptomatic acute pulmonary embolism (PE), symptomatic acute deep vein thrombosis (DVT), or asymptomatic acute proximal DVT. Of the 1,076 patients enrolled with acute VTE, 68.7% presented with an isolated DVT; 17.0% had PE alone; and 14.4% had both. VTE management was characterized by a high rate of inferior vena cava filter insertion (40.6%), frequent thrombolysis (21.1%), and sub-therapeutic unfractionated heparin-based anticoagulation, followed by warfarin prescription, mostly targeting an international normalized ratio of 2.0 (range, 1.5–2.5). During a mean observation period of 252.5 days, 29 recurrent cases of VTE were documented, yielding an incidence rate of 3.9 per 100 patient-years. A total of 123 patients died during the study period, corresponding to a rate of 16.6 deaths per 100 patient-years. The incidence of major bleeding was 3.2% per patient-year, including 2 fatal hemorrhages and 7 intracranial hemorrhages. Conclusions: VTE management in Japan is characterized by a highly aggressive strategy in the acute phase, in contrast to protocols that use low-level anticoagulation. The VTE recurrence rates in Japan and Western countries are similar, but mortality is higher in Japan, with significant variability depending on patient and management characteristics. (Circ J 2014; 78: 708–717)Keywords
This publication has 19 references indexed in Scilit:
- Oral Anticoagulant TherapyChest, 2012
- Epidemiology and Predictors of Short-Term Mortality in Symptomatic Venous Thromboembolism - A Nationwide Population-Based Study -Circulation Journal, 2011
- Guidelines for the Diagnosis, Treatment and Prevention of Pulmonary Thromboembolism and Deep Vein Thrombosis (JCS 2009)Circulation Journal, 2011
- Incidence and cumulative recurrence rates of venous thromboembolism in the Taiwanese populationJournal of Thrombosis and Haemostasis, 2010
- Clinical Predictors for Fatal Pulmonary Embolism in 15 520 Patients With Venous ThromboembolismCirculation, 2008
- Ximelagatran vs Low-Molecular-Weight Heparin and Warfarin for the Treatment of Deep Vein ThrombosisJAMA, 2005
- Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996Thrombosis and Haemostasis, 2005
- Fondaparinux or Enoxaparin for the Initial Treatment of Symptomatic Deep Venous ThrombosisAnnals of Internal Medicine, 2004
- Subcutaneous Fondaparinux versus Intravenous Unfractionated Heparin in the Initial Treatment of Pulmonary EmbolismNew England Journal of Medicine, 2003
- Clinical characteristics of acute pulmonary thromboembolism in Japan: Results of a multicenter registry in the japanese society of pulmonary embolism researchClinical Cardiology, 2001